TN-401 –Gene Therapy for PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Tenaya expects to complete enrollment of Cohort 1 of the RIDGE-1 Phase 1b clinical trial in the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback